Form 8-K - Current report:
SEC Accession No. 0001437749-24-027511
Filing Date
2024-08-21
Accepted
2024-08-21 17:16:12
Documents
23
Period of Report
2024-08-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K rvph20240821_8k.htm   iXBRL 8-K 44230
2 EXHIBIT 1.1 ex_717158.htm EX-1.1 253840
3 EXHIBIT 4.1 ex_717159.htm EX-4.1 86775
4 EXHIBIT 4.2 ex_717160.htm EX-4.2 98308
5 EXHIBIT 4.3 ex_717161.htm EX-4.3 101882
6 EXHIBIT 4.4 ex_717162.htm EX-4.4 12082
7 EXHIBIT 5.1 ex_717164.htm EX-5.1 12432
8 EXHIBIT 99.1 ex_717163.htm EX-99.1 11677
13 pic1.jpg GRAPHIC 7176
14 pic2.jpg GRAPHIC 9914
  Complete submission text file 0001437749-24-027511.txt   937944

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA rvph-20240820.xsd EX-101.SCH 3913
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rvph-20240820_def.xml EX-101.DEF 13476
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvph-20240820_lab.xml EX-101.LAB 17736
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvph-20240820_pre.xml EX-101.PRE 13453
25 EXTRACTED XBRL INSTANCE DOCUMENT rvph20240821_8k_htm.xml XML 4877
Mailing Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014
Business Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014 4085018881
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38634 | Film No.: 241229443
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)